The customer stated that they received erroneous results for one patient sample tested with elecsys ft3 iii, the elecsys ft4 ii assay, and the elecsys anti-tshr immunoassay on a cobas e 411 immunoassay analyzer.The ft3 and ft4 results from the e411 analyzer were higher than results obtained on an abbott architect analyzer.The physician also doubts the non-reactive anti-tshr result from the e411 analyzer.This medwatch will apply to the anti-tshr assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay and refer to the medwatch with patient identifier (b)(6) for information related to the ft4 assay.The patient sample was initially tested on the customer's e411 analyzer on (b)(6) 2018.The sample was repeated for ft3 and ft4 on an abbott architect analyzer.The sample was repeated for anti-tshr using the yamasa method.The sample was also provided for investigation where it was tested on an e 801 analyzer.No adverse events were alleged to have occurred with the patient.The serial number of the customer's e411 analyzer is (b)(4).The serial number of the e 801 analyzer used for investigation is (b)(4).Anti-tshr reagent lot number 359355, with an expiration date of november 2019 was used on this analyzer.
|